Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Embark Education thriving with childcare occupancy roaring past 80%
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Embark Education thriving with childcare occupancy roaring past 80%
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Embark Education thriving with childcare occupancy roaring past 80%
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Embark Education thriving with childcare occupancy roaring past 80%
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Embark Education thriving with childcare occupancy roaring past 80%
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • G8 Education profits surge amid fee hike increase coinciding with Child Care Subsidy increase, launches share buy back
    G8 Education profits surge amid fee hike increase coinciding with Child Care Subsidy increase, launches share buy back
    • News

  • Revenue increases, occupancy remains flat: G8 carries on with divestments and fee hikes in CY24
    Revenue increases, occupancy remains flat: G8 carries on with divestments and fee hikes in CY24
    • News

  • G8 Education issues 69% profit growth guidance, driven by managing educator wages
    G8 Education issues 69% profit growth guidance, driven by managing educator wages
    • News

  • G8 sells off 31 underperforming childcare centres to Genius Education for reallocation of resources
    G8 sells off 31 underperforming childcare centres to Genius Education for reallocation of resources
    • News

  • Mayfield Childcare reaches settlement to recoup $1 million from former CEO
    Mayfield Childcare reaches settlement to recoup $1 million from former CEO
    • News

  • Apiam wins $700k grant to build first viral vaccine manufacturing facility for animals
    • News

    Apiam wins $700k grant to build first viral vaccine manufacturing facility for animals

    As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX: AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing through the development of a state-of-the-art viral vaccine laboratory in Bendigo, Victoria.  Plans to develop the vaccine lab have been announced, supported

    Read More
    Public
  • Cycliq extends RL bike accessories into Fitness Metaverse with NFTs collectibles
    • News

    Cycliq extends RL bike accessories into Fitness Metaverse with NFTs collectibles

    As more ASX-listed companies identify the unique revenue opportunity to generate something out of nothing, bike accessories company Cycliq (ASX: CYQ) is joining the party with plans to mint NFT collectibles via a partnership with digital health company OliveX (NSX: OLX).  Known primarily for their safety equipment designed for cyclists such as cameras and lights,

    Read More
    Public
  • Gratifii’s customer loyalty tech reaches over 800 restaurants globally
    • News

    Gratifii’s customer loyalty tech reaches over 800 restaurants globally

    Since emerging from lockdown and COVID restrictions, the world has been busy catching up with friends and filling social calendars with coffees, dinners and drinks.  Full social calendars have meant full venues, with vendors breathing a collective sigh of relief now that things are pretty much back to normal. Enterprise loyalty and rewards business Gratifii

    Read More
    Public
  • Nyrada drug offers potential world first oral treatment for concussion
    • News

    Nyrada drug offers potential world first oral treatment for concussion

    Rummage through any garage and chances are you’ll find a can of WD40. The name arose after 39 failed attempts at creating the trademark degreaser. You know what they say, 40th time’s a charm.  In the pharmaceutical arena, failures, tweaks and fine-tuning are par for the course. Preclinical stage drug development company Nyrada (ASX: NYR)

    Read More
    Public
  • HR transformations through pandemic lead ELMO to launch Hybrid Work and Wellbeing modules
    • News

    HR transformations through pandemic lead ELMO to launch Hybrid Work and Wellbeing modules

    If there’s one division across all businesses that has undergone the largest operational changes, it’s probably human resources, which has had to deal with productivity, absenteeism, working from home and travel restrictions. Having identified how businesses can best manage these challenges, HR tech company ELMO Software (ASX: ELO) has launched new modules for its platform

    Read More
    Public
  • We wade through this radiopharmaceutical company’s news so you don’t have to
    • News

    We wade through this radiopharmaceutical company’s news so you don’t have to

    Seeing ‘Cu-64 SAR-bisPSMA’ in the title of an ASX announcement is enough to make many keep scrolling. However, clued in investors who read on and plug ‘radiopharmaceuticals’ into their search bar will uncover the massive market value of the space and its transformative potential. Clinical stage radiopharmaceutical company Clarity Pharmaceuticals (ASX: CU6) is an oncologyRead More
    Public
  • PainChek expands across New Zealand with pain tech deployed to 24 aged care facilities
    • News

    PainChek expands across New Zealand with pain tech deployed to 24 aged care facilities

    Confident in their technology that can accurately assess a patient’s pain simply from a short video of their face, medtech company PainChek (ASX: PCK) has successfully converted a 6-month trial with one of New Zealand’s largest aged care operators into a full revenue-generating contract. The contract comes after Summerset Holdings (ASX: SNZ) trialled PainChek’s smartphone

    Read More
    Public
  • German Ice Hockey Federation to trial HITIQ’s concussion tech mouthguards
    • News

    German Ice Hockey Federation to trial HITIQ’s concussion tech mouthguards

    With the AFL season having just kicked off, it didn’t take long for attention to be drawn to the league’s concussion protocols but having already partnered with the AFL, concussion tech company HITIQ (ASX: HIQ) has continued its international expansion having been engaged by the German Ice Hockey Federation. The long-term impact of concussion continues

    Read More
    Public
  • Predictive test for diabetic kidney disease receives new patent
    • News

    Predictive test for diabetic kidney disease receives new patent

    12% of global health expenditure is spent on diabetes. That equates to approximately USD $673 billion. Scarily, 1 in 2 adults with diabetes is undiagnosed.  Diabetic kidney disease (DKD) is directly caused by diabetes, and the damage the disease does to the kidneys. It is estimated that 1 in 3 diabetics will go on to

    Read More
    Public
  • Cettire founder cashes out $47m as boom stock comes back down to earth
    • News

    Cettire founder cashes out $47m as boom stock comes back down to earth

    If shareholder confidence is a sign of things to come, rocky waters may be ahead for luxury goods retailer Cettire (ASX: CTT) after its Founder and CEO cashed out $47.25 million of his shares with a pretty good idea of how their financial results for the year are going to look.  Keen investors have been

    Read More
    Public
  • «
  • ‹
  • 188
  • 189
  • 190
  • 191
  • 192
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.